Ozempic Linked With Lower Dementia Risk, Nicotine Use, British Study Finds (Reuters) - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems ...
Semaglutide, the main active ingredient in Ozempic, is linked to a lower risk of cognitive decline in a new study. The study only focused on patients with type 2 diabetes. Doctors say there may be ...
Diabetic study participants were less likely to develop cognitive deficits on Ozempic than other diabetes medications. Ozempic was also linked to a lower likelihood of smoking. The study found ...
New research suggests that the diabetes drug and popular weight loss treatment semaglutide, sold as Ozempic and Wegovy, is linked with a significantly lower risk of dementia — possibly adding to ...
Novo Nordisk A/S. NVO has found that its “miracle” weight loss drug used for diabetes, Ozempic, is linked to a significant reduction in the risk of dementia and other cognitive issues.
“A recent study conducted by the University of Oxford revealed that participants who used Semaglutide (the main ingredient in ...
(Reuters) - Novo Nordisk's popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published by researchers at Oxford University.
NOVO Nordisk’s popular diabetes treatment Ozempic could be tied to a lower risk of cognitive problems, according to an observational study published by researchers at Oxford University. The study, ...